Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Editorial

Nam Bui1

  • 1Department of Medicine/Oncology, Stanford University School of Medicine, Stanford, CA.

Current Problems in Cancer
|September 13, 2019
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Related Concept Videos

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

8.7K
In the past many in vitro culture systems -- mainly monolayer cultures -- often suffered from the disadvantage that differentiated primary cells had a relatively short life-span and de-differentiated during culture. As a consequence, most of their organ-specific functions were lost rapidly. Thus, in order to reproduce better conditions for these cells in vitro, modifications and adaptations have been made to conventional monolayer...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and implementation of cancer clinical trial patient screening using an electronic medical record-integrated trial matching system.

BMJ health & care informatics·2025
Same author

<i>Anaerobutyricum soehngenii</i> improves glycemic control and other markers of cardio-metabolic health in adults at risk of type 2 diabetes.

Gut microbes·2025
Same author

Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult Patients.

Cancers·2025
Same author

Clinical evaluation of a polarization-based optical noninvasive glucose sensing system.

Scientific reports·2025
Same author

Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease.

Therapeutic advances in rare disease·2025
Same author

Recent advances in sarcoma therapy: new agents, strategies and predictive biomarkers.

Journal of hematology & oncology·2024